USFDA nod for cancer biosimilar is a big triumph: Kiran Mazumdar Shaw

After initial hiccups with the US and EU drug regulators, Shaw said this approval signifies India and her company ’s capability in developing complex drugs.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news